| 1. | The other 75 per cent of lung cancers consist of a variety of "non-small cell cancers" . 其余75的肺癌属于各种“非小细胞肺癌”。 |
| 2. | Expression of cathepsin l in non - small cell lung carcinoma 在非小细胞肺癌组织中的表达 |
| 3. | Non - small cell lung cancer , nsclc 目的探讨氨基酸肠外营养对非小细胞肺癌 |
| 4. | Topotecan for small cell lung cancer : a systematic review 拓扑替康治疗小细胞肺癌的系统评价 |
| 5. | Trend of molecular target therapy of non - small cell lung cancer 非小细胞肺癌生物靶点治疗的动向 |
| 6. | Keyword : zd1839 nsclc disease control rates adverse events 关键词: zd1839非小细胞肺癌控制率不良事件。 |
| 7. | Keyword : zd1839 clc disease control rates adverse events 关键词: zd1839非小细胞肺癌疾病控制率不良事件。 |
| 8. | Keyword : zd1839 nsclc disease control rates adverse events 关键词: zd1839非小细胞肺癌疾病控制率不良事件。 |
| 9. | The application of topotecan in treatment of small cell lung cancer 拓扑替康联合顺铂治疗小细胞肺癌疗效观察 |
| 10. | Nonsmall cell lung cancer , sclc 其中非小细胞肺癌 |